The Effect of Food Intake During Hemodialysis on Blood Pressure
NCT ID: NCT05405348
Last Updated: 2022-06-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
54 participants
INTERVENTIONAL
2019-01-01
2019-03-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
This nonrandomized experimental trial investigated the effect of food intake during hemodialysis on blood pressure of patients. The sample consisted of 54 chronic patients receiving hemodialysis treatment. Researchers monitored the patients in two hemodialysis sessions; first meeting (T0) and second meeting (T1) which is one week later from T0. In the first meeting which is ''hemodialysis in fed state'', they ate the standard food served by the clinic at regular hours which means routine care of hemodialysis clinic. In the second meeting which is ''hemodilaysis in fasting state'', they did not eat anything during hemodialysis which means intervention part of the study. Both hemodyalisis in fed and fasting state, researchers recorded patient's blood pressure were monitozied in the mid-hemodiyalsis sessions. Patient' s sociodemographic and disease characteristics were recorded. Patient' s blood pressure monitorized by the ambulatory blood pressure monitor.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Volume,Sodium and Blood Pressure Management in HD
NCT01766882
Low Sodium Dialysate and Ambulatory Blood Pressure Measurement Parameters
NCT02621450
Diet Therapy in Hemodialysis Patients
NCT06215339
Reducing Dialysate Sodium Effect on Blood Pressure Variability in Hemodialysis Patients
NCT05169125
Can Dietitians Reduce Interdialytic Weight Gain in at Risk Hemodialysis Patients Through Tailored Education on Dietary Sodium and Fluid Intake?
NCT02130089
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Blood pressure measurements were made using Suntech Bravo Ambulatory Blood Pressure Monitoring (Morrisville, USA). Blood pressure was evaluated in the supine position with the use of a brachial cuff. The blood pressure measurement was made in the midweek dialysis session on the day of the measurement. Before the patient entered hemodialysis, an ambulatory blood pressure monitor was placed and blood pressure was measured at 15-minute intervals throughout the 4-hour hemodialysis session. A total of 16 measurements were made. The patients did not consume any food during the 4-hour dialysis session.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
CROSSOVER
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control
The control group received routine care (T0)
No interventions assigned to this group
Intervention
Same patients, one week after T0, T1 was applied in middialysis. In T1, patients did not consume food at least half an hour before coming to hemodialysis. They also did not consume any food during hemodialysis.
Intervention
The patients did not eat anything during hemodialysis.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Intervention
The patients did not eat anything during hemodialysis.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Having CKD and being in the hemodialysis program
* Having the ability to understand and speak
* Being on HD treatment for 6 months or longer
* Weight gain of 4 kg or less between two HD sessions
* Standard HD is applied 3 days a week for 4 hours
Exclusion Criteria
* Being on dialysis for less than 6 months,
* Interdialytic weight gain of more than 4kg,
* The patient is not suitable for blood pressure measurement from the arm,
* The patient used antihypertensive before HD,
* Entering HD less than or more than 3 days a week,
* More or less than 4 hours of HD input.
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
melek avcı
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
melek avcı
Department of Internal Medicine Nursing, MsC, RN
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Melek Avcı, PhD Student
Role: STUDY_DIRECTOR
Akdeniz University
Fatma Arikan, PhD, RN
Role: PRINCIPAL_INVESTIGATOR
Akdeniz University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Akdeniz University
Antalya, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2012-KAEK-20-547
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.